Abstract
Sialyltransferases which add sialic acid with α2,3-, α2,6-, or α2,8-linkages contribute to the terminal of carbohydrate structures and functions of cell surface molecules including glycolipids and glycoproteins (Tsuji et al. 1996; Harduin-Lepers et al. 2001; Audry et al. 2011). Glycans with α2,3-linked sialic acids present on cell surface are known as receptors of viruses such as influenza viruses and target molecules of siglecs, which contain an immunoglobulin domain with lectin activity capturing sialic acids. So far, there are six α2,3-sialyltransferases in mammal genome. The first cDNA of ST3GAL1 was cloned based on the deduced peptide sequences of purified α2,3-sialyltransferase from porcine liver (Gillespie et al. 1992), and orthologues have been found in many vertebrate genomes. Since ST3GAL1 has a strict acceptor specificity toward type III glycans (Galβ1→3GalNAc), ST3GAL1 predominantly adds sialic acid to the core 1 O-glycan, Galβ1→3GalNAc→Ser/Thr, which is a major core structure of mucin-type O-glycans. For instance, the resulting oligosaccharide product is a sialylated core 1 O-glycan, NeuAcα2→3Galβ1→3GalNAc→Ser/Thr, which is also further sialylated by certain α2,6-sialyltransferases, generating a fully sialylated tetrasaccharide: NeuAcα2→3Galβ1→3(NeuAcα2→6)GalNAc→Ser/Thr (Fig. 57.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Audry M, Jeanneau C, Imberty A, Harduin-Lepers A, Delannoy P, Breton C (2011) Current trends in the structure-activity relationships of sialyltransferases. Glycobiology 21:716–726
Angata K, Yen TY, El-Battari A, Macher BA, Fukuda M (2001) Unique disulfide bond structures found in ST8Sia IV polysialyltransferase are required for its activity. J Biol Chem 276:15369–15377
Baum LG, Pang M, Perillo NL, Wu T, Delegeane A, Uittenbogaart CH, Fukuda M, Seilhamer JJ (1995) Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med 181:877–887
Burchell J, Poulsom R, Hanby A, Whitehouse C, Cooper L, Clausen H, Miles D, Taylor-Papadimitriou J (1999) An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 9:1307–1311
Dalziel M, Whitehouse C, McFarlane I, Brockhausen I, Gschmeissner S, Schwientek T, Clausen H, Burchell JM, Taylor-Papadimitriou J (2001) The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. J Biol Chem 276:11007–11015
Datta AK, Chammas R, Paulson JC (2001) Conserved cysteines in the sialyltransferase sialylmotifs form an essential disulfide bond. J Biol Chem 276:15200–15207
Ellies LG, Sperandio M, Underhill GH, Yousif J, Smith M, Priatel JJ, Kansas GS, Ley K, Marth JD (2002) Sialyltransferase specificity in selectin ligand formation. Blood 100:3618–3625
Gillespie W, Kelm S, Paulson JC (1992) Cloning and expression of Gal β1,3GalNAc α 2,3- sialyltransferase. J Biol Chem 267:21004–21010
Gillespie W, Paulson JC, Kelm S, Pang M, Baum LG (1993) Regulation of α2,3- sialyltransferase expression correlates with conversion of peanut agglutinin (PNA) + to PNA- phenotype in developing thymocytes. J Biol Chem 268:3801–3804
Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P (2001) The human sialyltransferase family. Biochimie 83:727–737
Jeanneau C, Chazalet V, Augé C, Soumpasis DM, Harduin-Lepers A, Delannoy P, Imberty A, Breton C (2004) Structure-function analysis of the human sialyltransferase ST3Gal I: role of n-glycosylation and a novel conserved sialylmotif. J Biol Chem 279:13461–13468
Kitagawa H, Paulson JC (1994) Differential expression of five sialyltransferase genes in human tissues. J Biol Chem 269:17872–17878
Kono M, Ohyama Y, Lee YC, Hamamoto T, Kojima N, Tsuji S (1997) Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology 7:469–479
Kurosawa N, Hamamoto T, Inoue M, Tsuji S (1995) Molecular cloning and expression of chick Gal β1,3GalNAc α2,3-sialyltransferase. Biochim Biophys Acta 1244:216–222
Lantéri M, Giordanengo V, Hiraoka N, Fuzibet JG, Auberger P, Fukuda M, Baum LG, Lefebvre JC (2003) Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. Glycobiology 13:909–918
Lee YC, Kurosawa N, Hamamoto T, Nakaoka T, Tsuji S (1993) Molecular cloning and expression of Gal β1,3GalNAc α2,3-sialyltransferase from mouse brain. Eur J Biochem 216:377–385
Picco G, Julien S, Brockhausen I, Beatson R, Antonopoulos A, Haslam S, Mandel U, Dell A, Pinder S, Taylor-Papadimitriou J, Burchell J (2010) Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology 20:1241–1250
Piller F, Piller V, Fox RI, Fukuda M (1988) Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J Biol Chem 263:15146–15150
Priatel JJ, Chui D, Hiraoka N, Simmons CJ, Richardson KB, Page DM, Fukuda M, Varki NM, Marth JD (2000) The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity 12:273–283
Rao FV, Rich JR, Rakic B, Buddai S, Schwartz MF, Johnson K, Bowe C, Wakarchuk WW, Defrees S, Withers SG, Strynadka NC (2009) Structural insight into mammalian sialyltransferases. Nat Struct Mol Biol 16:1186–1188
Skrincosky D, Kain R, El-Battari A, Exner M, Kerjaschki D, Fukuda M (1997) Altered Golgi localization of core 2 beta-1,6-N-acetylglucosaminyltransferase leads to decreased synthesis of branched O-glycans. J Biol Chem 272:22695–22702
Sproviero D, Julien S, Burford B, Taylor-Papadimitriou J, Burchell JM (2012) Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer. J Biol Chem 287:44490–44497
Sturgill ER, Aoki K, Lopez PH, Colacurcio D, Vajn K, Lorenzini I, Majic S, Yang WH, Heffer M, Tiemeyer M, Marth JD, Schnaar RL (2012) Biosynthesis of the major brain gangliosides GD1a and GT1b. Glycobiology 22:1289–1301
Takashima S (2008) Characterization of mouse sialyltransferase genes: their evolution and diversity. Biosci Biotechnol Biochem 72:1155–1167
Tsuji S, Datta AK, Paulson JC (1996) Systematic nomenclature for sialyltransferases. Glycobiology 6:v–vii
Van Dyken SJ, Green RS, Marth JD (2007) Structural and mechanistic features of protein O glycosylation linked to CD8+ T-cell apoptosis. Mol Cell Biol 27:1096–1111
Videira PA, Correia M, Malagolini N, Crespo HJ, Ligeiro D, Calais FM, Trindade H, Dall’Olio F (2009) ST3Gal. I sialyltransferase relevance in bladder cancer tissues and cell lines. BMC Cancer 9:357
Whitehouse C, Burchell J, Gschmeissner S, Brockhausen I, Lloyd KO, Taylor-Papadimitriou J (1997) A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans. J Cell Biol 137:1229–1241
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this entry
Cite this entry
Angata, K., Fukuda, M. (2014). ST3 Beta-Galactoside Alpha-2,3-Sialyltransferase 1 (ST3GAL1). In: Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., Angata, T. (eds) Handbook of Glycosyltransferases and Related Genes. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54240-7_27
Download citation
DOI: https://doi.org/10.1007/978-4-431-54240-7_27
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54239-1
Online ISBN: 978-4-431-54240-7
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences